Send the following on WhatsApp
Continue to ChatAeglea Biotherapeutics 旗下精氨酸酶缺乏症藥品 Pegzilarginase 獲得 EMA 上市許可 https://geneonline.news/aeglea-biotherapeutics-pegzilarginase-ema/?variant=zh-cn
Aeglea Biotherapeutics 旗下精氨酸酶缺乏症藥品 Pegzilarginase 獲得 EMA 上市許可 https://geneonline.news/aeglea-biotherapeutics-pegzilarginase-ema/?variant=zh-cn